ICON adds two to leadership teams in Asia Pacific and Latin America

Friday, September 28, 2012 02:47 PM

ICON, a global provider of outsourced development services, has appointed new members to its Asia Pacific & Latin American teams. New members include Wei Ming Goh as vice president of Asia Pacific and Dennis Hurley as vice president of Latin America.

Goh has over 14 years of experience within the CRO industry and a strong track record in Asia Pacific. He joins ICON from Kendle where he served as vice president of Asia Pacific and was responsible for all operational activities and partner relationships within the region. Prior to this, Goh spent 11 years with Quintiles, and held a number of senior management positions in operations and finance for the company’s Asian, Australian and African region. He has also held senior roles in Asia with Autodesk, The Ask Group and Hitachi Data Systems.

Hurley has 30 years’ experience within the drug development industry and joins ICON from INC where, as vice president of Latin America, he was responsible for building the company’s business in the region. Hurley co-founded ECA, Mexico’s largest CRO, in 1992 and expanded it to the five other major countries in Latin America. As well as his operational leadership in clinical development, he has a strong background in biostatistics, process improvement, project management and has contributed significantly to a number of approved NDAs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs